flying bird

Tricks and Tips

Tuesday 27 November 2018

MARKET WRAP UP 27-NOV-2018


Closing Bell: Sensex ends 159 points higher, Nifty at 10,685; Infosys up 3%.

It’s a green close for the market on Tuesday, with the Nifty ending well above 10,650-mark.
A rally among PSU banks, energy names as well as IT boosted the market. In the broader market, the Nifty Midcap index ended over half a percent higher.
At the close of market hours, the Sensex ended up 159.06 points or 0.45% at 35513.14, while the Nifty was higher by 57.00 points or 0.54% at 10685.60. The market breadth was narrow as 1238 shares advanced, against a decline of 1320 shares, while 161 shares were unchanged.
Infosys, TCS, and BPCL were the top gainers, while Sun Pharma and Hero MotoCorp lost the most.


HEADLINES OF THE DAY


Punjab National Bank shares gained 2.5 per cent after the lender expects Rs 2,500 crore recovery from Essar Steel resolution.
Zydus Cadila gets USFDA approval: Zydus Cadila has received the final approval from the USFDA to market Baclofen Tablets, 10 mg and 20 mg. It will be manufactured at the group’s formulations manufacturing facility at Baddi.
Lupin gets EIR from USFDA: The company has received EIR (Establishment Inspection Report) on the completion of an inspection by the USFDA (United States Food & Drug Administration) at its facility in Tarapur, Maharashtra.
USFDA approves ANDA filed by Granules Pharma.
Jet Airways salary payment: PTI reported that Jet Airways will pay the remaining 25 per cent September salary to its senior staff early next month and is likely to come out with a revised payment schedule soon, a source at the airline said.


The crucial resistance for the Nifty spot is now seen at 10720 and above this 10920 Support for the immediate term is now placed at 10480 next support will be 10370.


Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

0 comments:

Post a Comment